Understanding Regulatory Pathways for Biosimilars in the Legal Framework
Regulatory pathways for biosimilars guide their transition from development to approved medical products, ensuring safety, efficacy, and quality. Understanding the Food and Drug Administration (FDA) approval process is crucial for navigating these complex regulatory frameworks. Overview of Regulatory Pathways for Biosimilars in the U.S. The regulatory pathways for biosimilars in the United States are primarily … Read more